Normal Curves: Sexy Science, Serious Statistics

Cancer Blood Tests: Are they ready for primetime? Part 1

Normal Curves: Sexy Science, Serious Statistics

Show Notes

Can a single tube of blood really detect dozens of cancers before symptoms appear? We dive into the science behind Galleri, a blood test that claims to detect more than 50 types of cancer from a simple blood draw. Recent headlines about the test ranged from “breakthrough” to “bust” after the release of results from a massive randomized clinical trial. In this Part 1 episode, we explore cell-free DNA, DNA methylation, machine learning, sensitivity, specificity, and positive predictive value. Along the way, we revisit the prenatal screening revolution, ask why detecting cancer earlier doesn’t always help patients, and learn how escaped DNA convicts end up swimming in a giant molecular pool party. And for the first time ever, Normal Curves ends on a cliffhanger: we’ll save the controversial results of that landmark trial for Part 2. Statistical topics cancer screening case-control studies counterfactuals machine learning negative predictive value overdiagnosis positive predictive value randomized clinical trials screening tests sensitivity and specificity validation

References Bianchi DW, Chudova D, Sehnert AJ, et al. Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA. 2015; 314:162-9. Liu MC, Oxnard GR, Klein EA, et al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol. 2020. 31:745-59. Schrag D, Beer T, McDonnell C et al. Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study. The Lancet. 402: 1251-60. Giridhar KV, et al. Safety and performance results from PATHFINDER 2, a registrational study of a multi-cancer early detection test in an intended-use population. Presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. May 2026.

Statistic discussed in the episode

PATHFINDER 2 investigators reported that adding Galleri to routine screening increased the number of screen-detected cancers by 6.5-fold. This figure compares 31 cancers detected through USPSTF-recommended screening (for breast, cervical, lung, and colon) with 204 cancers detected when Galleri was added, counting the same 31 conventional-screening cancers in both totals. Thus, describing the increase as 6.5-fold is misleading, since the combination of Galleri plus conventional screening is, by definition, guaranteed to detect at least as many cancers as conventional screening alone. Moreover, everyone in the study received Galleri, whereas conventional screening depended on which tests participants happened to be due for and completed during the study period. The comparison therefore does not involve two equally applied screening strategies.

Kristin and Regina’s online courses:

Demystifying Data: A Modern Approach to Statistical Understanding Clinical Trials: Design, Strategy, and Analysis Medical Statistics Certificate Program Writing in the Sciences Epidemiology and Clinical Research Graduate Certificate Program Programs that we teach in: Epidemiology and Clinical Research Graduate Certificate Program

Find us on: Kristin - LinkedIn & Twitter/X Regina - LinkedIn & ReginaNuzzo.com

(00:00) - - Introduction

(00:44) - - The Holy Grail of Cancer Testing

(04:31) - - Headlines: Same Data, Opposite Stories

(07:38) - - How Cell-Free DNA Works

(13:54) - - DNA Methylation: GRAIL's Fingerprint

(15:19) - - The Origin Story

(22:18) - - The Pathfinder Studies

(35:01) - - The Paradox: Why Earlier Detection Doesn't Always Help

(40:32) - - The Cliffhanger

More from Normal Curves: Sexy Science, Serious Statistics

Oct 19, 2026

A famous Harvard researcher. A blockbuster finding about honesty. Suspicious data, failed replications, and a $25 million lawsuit. Welcome to one of the strangest research misconduct scandals in recent memory. In the first of two episodes about the Francesca Gino case, we investigate a famous experiment claiming that signing an honesty pledge at the top of a form makes people less likely to cheat. We follow the trail from a failed replication to some extraordinary detective work involving an Excel spreadsheet—and conduct a little statistical sleuthing of our own. Along the way, we discover how suspicious changes to a handful of observations can alter the story a scientific study tells. Statistical topics Statistical sleuthing Data integrity Data management Replication Sensitivity analysis Effect sizes Statistical significance Reproducibility Spreadsheets Conceptual replication Direct replication CalcChain Methodologic Morals “There's cleaning your data, and then there's laundering your data.” “Good data record keeping is still sexy. Version control, baby.”

Oct 5, 2026

Can you spot problems in a scientific study just by reading the published paper? We put our statistical sleuthing skills to the test with a famous study on procrastination and deadlines that was retracted more than 20 years after it was published. But were there clues hidden in plain sight in the published results—and would we have noticed anything suspicious at the time? We put on our data-detective hats and find a few statistical clues of our own before turning to Data Colada’s investigation of the original data, where the story gets even stranger. Along the way, we hunt for missing participants, question suspiciously enormous effects, meet some unlikely data twins, and discover why sometimes the best statistical tool is simply asking: Do these data behave like real people?

Sep 21, 2026

What happens when you discover that your published paper is wrong? Does retracting it ruin your reputation—or could owning the mistake actually make things better? In this episode, we meet the inaugural winners of the Ctrl-Z Awards, which recognize scientists for correcting or retracting their own work. Behavioral ecologist Kate Laskowski takes us inside a scientific detective story involving suspicious spider data, three retracted papers, and the fear that going public might tank her career. Then computational social scientist Alyssa Smith tells us how one small error in a figure led her to retract the paper at the center of her PhD and job talk. Along the way, we talk about data forensics, the stigma around retractions, and why self-correcting scientists are the heart of science.

Sep 7, 2026

Statistical power is one of the most important ideas in statistics—and one of the most misunderstood. In this episode, we explain what statistical power really means, why researchers need to think about it before they collect their data, and what goes wrong when they calculate “post hoc power” after the study is over. Along the way, we hunt for UFOs, test Kristin’s psychic abilities, explore the ethics of underpowered studies, and discover why post hoc power is really just a p-value wearing a fake mustache. Then statistician and powerlifter Andrew Althouse joins us for the inside story of a years-long scientific feud over post hoc power, where we discuss what happens when being wrong about statistics turns into doubling down, angry letters to the editor, and debates about how science corrects itself.

Aug 24, 2026

Can weed protect your brain as you get older? We unpack a study linking lifetime cannabis use to larger brain volumes and better cognitive test scores in older adults—and investigate how those findings became headlines urging readers to “pass the pot to grandma.” Along the way, we explore collapsing categorical variables, confounding, clinically versus statistically significant results, multiple testing, and how a press release subtly changed a story. We also meet permanently stoned mice, learn about Carl Sagan’s surprising connection to cannabis research, and discover how a single missing word can change the entire meaning of a study. Statistical topics Categorical variables Confounding Effect size False discovery rate Healthy volunteer bias Measurement error Multiple testing Observational studies Recoding variables Science communication Statistical vs practical significance

See all episodes →